Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2018. Start Trial.
Date Value
November 12, 2026 1.116
November 11, 2026 1.062
November 10, 2026 1.089
November 09, 2026 1.180
November 06, 2026 1.175
November 05, 2026 1.22
November 04, 2026 1.332
November 03, 2026 1.459
November 02, 2026 1.589
October 30, 2026 1.495
October 29, 2026 1.544
October 28, 2026 1.558
October 27, 2026 1.495
October 26, 2026 1.418
October 23, 2026 1.404
October 22, 2026 1.378
October 21, 2026 1.396
October 20, 2026 1.386
October 19, 2026 1.306
October 16, 2026 1.188
October 15, 2026 1.296
October 14, 2026 1.332
October 13, 2026 1.396
October 12, 2026 1.432
October 09, 2026 1.441
Date Value
October 08, 2026 1.378
October 07, 2026 1.404
October 06, 2026 1.423
October 05, 2026 1.513
October 02, 2026 1.549
October 01, 2026 1.540
September 30, 2026 1.621
September 29, 2026 1.631
September 28, 2026 1.605
September 25, 2026 1.666
September 24, 2026 1.702
September 23, 2026 1.728
September 22, 2026 1.834
September 21, 2026 1.869
September 18, 2026 1.843
September 17, 2026 1.816
September 16, 2026 1.799
September 15, 2026 1.781
September 14, 2026 1.869
September 11, 2026 1.843
September 10, 2026 1.808
September 09, 2026 1.843
September 08, 2026 1.913
September 04, 2026 1.958
September 03, 2026 1.966

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
MediGene AG --
BioNTech SE 1.056
Immatics NV 1.954
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. --

Price to Book Value Related Metrics

PS Ratio 4262.00
Price 1.17
Earnings Yield -36.44%
Market Cap 172.42M